Serum Institute of India (SII), the world’s biggest vaccine maker by volume, on Sunday asked for patience from foreign governments awaiting their supply of COVID-19 shots, saying it had been directed to prioritise India’s requirements.
After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine “COVISHIELD”, its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the central government for the support.
The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine “Covishield” in the country.
English
English
English
